Clinical data showed that quercetin (1 g daily for 12 weeks) improved adiponectin-mediated IR and metabolic disorder by increasing total adiponectin and high molecular weight adiponectin and reducing resistin, which promoted IR and hyperinsulinemia (Khorshidi et al., 2018). Here, ADIPOQ is linked to metabolic disease.